Income Statement Acron

Stocks

AKRN

RU0009028674

Agricultural Chemicals

End-of-day quote Moscow Micex - RTS 2022-07-08			5-day change	1st Jan Change
18,362.00 ^RUB	-0.22%		-.--%	-

05-15	Public Joint Stock Company Acron Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Russia lacks capacity to ramp up fertilizer exports, industry lobby says	RE

8c4dace8411da9.LUnUrEE4zJ2vXNc5pIgImsUEDB5ZPRMmsQoJqfzcXtE.dz-z2SRyutvkFoYB6f869IwpZHMAe3JtyT1H4J-wDIlOAYGBNACdsN4Qkg

Published financial data: ACRON

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2022	2023	2024	2025
Revenues	120B	257B	179B	198B	238B
Total Revenues	120B	257B	179B	198B	238B
Cost of Goods Sold, Total	65.82B	89.88B	88.8B	96.73B	119B
Gross Profit	54.05B	167B	90.66B	101B	119B
Selling General & Admin Expenses, Total	29.82B	34.02B	27.98B	37.27B	37.42B
Impairment of Oil, Gas & Mineral Properties - (IS)	-	-	-	-	17.5B
Other Operating Expenses	1.02B	9.03B	6.44B	16.53B	4.33B
Other Operating Expenses, Total	30.84B	43.05B	34.42B	53.8B	59.25B
Operating Income	23.2B	124B	56.23B	47.63B	59.31B
Interest Expense, Total	-3.28B	-2.97B	-3.94B	-5.26B	-3.55B
Interest And Investment Income	111M	1.04B	3.66B	5.18B	3.63B
Net Interest Expenses	-3.17B	-1.94B	-281M	-79M	77M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-10.74B	2.62B	-324M	-5.87B	-5.45B
Other Non Operating Income (Expenses)	-4.53B	-9.15B	-3.79B	-1.68B	-159M
EBT, Excl. Unusual Items	4.77B	116B	51.84B	40.01B	53.78B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	640M	-157M	-65M	-344M	-264M
Asset Writedown	-	-1.18B	-782M	-	-
EBT, Incl. Unusual Items	5.41B	114B	50.99B	39.66B	53.52B
Income Tax Expense	1.57B	23.43B	15.12B	9.14B	13.74B
Earnings From Continuing Operations	3.84B	91.03B	35.87B	30.52B	39.78B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	3.84B	91.03B	35.87B	30.52B	39.78B
Minority Interest	-526M	-600M	-145M	-81M	-133M
Net Income - (IS)	3.31B	90.43B	35.72B	30.44B	39.64B
Net Income to Common Incl Extra Items	3.31B	90.43B	35.72B	30.44B	39.64B
Net Income to Common Excl. Extra Items	3.31B	90.43B	35.72B	30.44B	39.64B
Per Share Items
Net EPS - Basic	87.71	2.46K	973.26	834.14	1.09K
Basic EPS - Continuing Operations	87.71	2.46K	973.26	834.14	1.09K
Basic Weighted Average Shares Outstanding	37.74M	36.75M	36.7M	36.49M	36.43M
Net EPS - Diluted	87.68	2.45K	971.24	834.14	1.09K
Diluted EPS - Continuing Operations	87.68	2.45K	971.24	834.14	1.09K
Diluted Weighted Average Shares Outstanding	37.75M	36.84M	36.78M	36.49M	36.43M
Normalized Basic EPS	65.06	1.95K	878.76	682.98	918.99
Normalized Diluted EPS	65.04	1.95K	876.93	682.98	918.99
Dividend Per Share	30	-	427	534	-
Payout Ratio	496.92	6.35	-	33.89	43.55
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	34.77B	136B	68.74B	60.72B	91.67B
EBITA	23.22B	124B	56.25B	47.65B	59.31B
EBIT	23.2B	124B	56.23B	47.63B	59.31B
EBITDAR	36.59B	139B	70.98B	63.78B	94.44B
Effective Tax Rate - (Ratio)	29.09	20.47	29.66	23.05	25.67
Total Current Taxes	1.74B	24.16B	18.54B	7.69B	11.18B
Total Deferred Taxes	-169M	-728M	-3.42B	1.45B	2.56B
Normalized Net Income	2.46B	71.78B	32.25B	24.92B	33.48B
Interest Capitalized	4.26B	394M	3.41B	10.28B	16.08B
Interest on Long-Term Debt	4.44B	-	-	-	-
Supplemental Operating Expense Items
Marketing Expenses	117M	73M	51M	62M	47M
Selling and Marketing Expenses	117M	73M	51M	62M	47M
Research And Development Expense From Footnotes	-	378M	43M	56M	45M
Net Rental Expense, Total	1.83B	2.23B	2.24B	3.06B	2.77B
Imputed Operating Lease Interest Expense	1.06B	-	1.42B	2.71B	2.75B
Imputed Operating Lease Depreciation	761M	-	817M	343M	26.03M

Fiscal Period: December	2020	2022	2023	2024	2025
Assets
Cash And Equivalents	15.54B	38.47B	78.42B	68.34B	25.74B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	15.54B	38.47B	78.42B	68.34B	25.74B
Accounts Receivable, Total	6.2B	38.69B	22.1B	30.74B	22.16B
Other Receivables	3.89B	7.63B	6.74B	9.22B	10.72B
Notes Receivable	307M	280M	542M	187M	176M
Total Receivables	10.4B	46.6B	29.38B	40.15B	33.05B
Inventory	19.3B	29.56B	33.66B	35.85B	33.28B
Other Current Assets, Total	2.32B	5.16B	8.71B	9.15B	6.02B
Total Current Assets	47.56B	120B	150B	153B	98.09B
Gross Property Plant And Equipment	242B	288B	340B	398B	463B
Accumulated Depreciation	-86.47B	-104B	-117B	-130B	-158B
Net Property Plant And Equipment	156B	184B	223B	268B	305B
Long-term Investments	11.26B	-	-	-	-
Goodwill	-	-	-	-	-
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	179M	204M	923M	600M	447M
Other Long-Term Assets, Total	5.57B	17.18B	13.95B	16.8B	15.45B
Total Assets	220B	321B	388B	439B	419B
Liabilities
Accounts Payable, Total	7.62B	7.57B	12.12B	12.18B	11.16B
Accrued Expenses, Total	2.84B	5.84B	8.26B	9.18B	9.85B
Short-term Borrowings	36.91B	9.22B	57.62B	92.58B	65.02B
Current Portion of Leases	456M	285M	698M	330M	217M
Current Income Taxes Payable	1.66B	3.58B	-	398M	1.1B
Other Current Liabilities	9.93B	13.83B	15.58B	20.72B	23.52B
Total Current Liabilities	59.4B	40.32B	94.26B	135B	111B
Long-Term Debt	78.2B	68.68B	45.9B	79.1B	75.76B
Long-Term Leases	2.25B	1.39B	1.65B	2.17B	1.88B
Deferred Tax Liability Non Current	8.47B	7.59B	4.9B	7.61B	10.54B
Other Non Current Liabilities	2.96B	7.84B	10.26B	5.12B	2.24B
Total Liabilities	151B	126B	157B	229B	201B
Common Stock, Total	3.05B	2.76B	2.76B	2.76B	2.76B
Retained Earnings	57.91B	171B	206B	213B	226B
Treasury Stock	-17M	-	-	-2M	-1M
Comprehensive Income and Other	-18.24B	-5.1B	-5.55B	-13.66B	-13.88B
Total Common Equity	42.7B	168B	204B	202B	215B
Minority Interest	26.1B	26.78B	27.21B	7.51B	2.2B
Total Equity	68.8B	195B	231B	210B	217B
Total Liabilities And Equity	220B	321B	388B	439B	419B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	37.22M	36.73M	36.69M	36.3M	36.51M
ECS Total Common Shares Outstanding	37.22M	36.73M	36.69M	36.3M	36.51M
Book Value / Share	1.15K	4.58K	5.55K	5.56K	5.89K
Tangible Book Value	42.7B	168B	204B	202B	215B
Tangible Book Value Per Share	1.15K	4.58K	5.55K	5.56K	5.89K
Total Debt	118B	79.57B	106B	174B	143B
Net Debt	102B	41.1B	27.44B	106B	117B
Debt Equivalent Oper. Leases	14.61B	17.87B	17.88B	24.44B	22.18B
Minority Interest, Total (Incl. Fin. Div)	26.1B	26.78B	27.21B	7.51B	2.2B
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	6	-	3	3	3
Inventories - Raw Materials, Total	10.57B	19.48B	20.57B	23.44B	28.32B
Inventories - Work In Process, Total	510M	655M	895M	657M	863M
Inventories - Finished Goods, Total	8.5B	9.43B	12.19B	11.76B	5.21B
Land - (BS)	2.53B	2.56B	2.57B	2.47B	2.47B
Buildings, Total	48.81B	54.49B	58.05B	62.51B	65.26B
Machinery, Total	65.09B	73.98B	84.61B	92.2B	107B
Accumulated Allowance for Doubtful Accounts (Supple)	39M	6.11B	4.04B	1.88B	962M

Fiscal Period: December	2020	2022	2023	2024	2025
Net Income	3.31B	90.43B	35.72B	30.44B	39.64B
Depreciation & Amortization - CF	12.09B	12.04B	12.49B	13.08B	14.86B
Amortization of Goodwill and Intangible Assets - (CF)	12M	12M	12M	12M	2M
Impairment of Oil, Gas & Mineral Properties - (CF)	-	-	-	-	17.5B
Depreciation & Amortization, Total	12.11B	12.05B	12.51B	13.09B	32.36B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-640M	157M	65M	344M	264M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	1.18B	782M	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	6.07B	-798M	-1.85B	-913M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	13.6B	2.99B	-3.75B	-4.32B	-24.33B
Change In Accounts Receivable	-3.09B	-35.67B	18.66B	-6.48B	9.5B
Change In Inventories	-3.28B	-2.34B	-8.22B	-4.96B	3.02B
Change In Accounts Payable	596M	-939M	4.55B	-276M	-1.02B
Change in Unearned Revenues	-	1.08B	-2.37B	-1.47B	-225M
Change in Other Net Operating Assets	3.59B	-9.58B	5.24B	-424M	-1.54B
Cash from Operations	26.19B	65.45B	62.38B	24.09B	56.77B
Capital Expenditure	-17.95B	-29.46B	-45.28B	-46.54B	-54.54B
Sale of Property, Plant, and Equipment	1.11B	-	-	-	-
Investment in Marketable and Equity Securities, Total	-60M	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-283M	653M	244M	7.7B	602M
Cash from Investing	-17.18B	-28.81B	-45.03B	-38.84B	-53.94B
Short Term Debt Issued, Total	-	-	-	-	400M
Long-Term Debt Issued, Total	39.24B	2.15B	30.31B	103B	110B
Total Debt Issued	39.24B	2.15B	30.31B	103B	110B
Short Term Debt Repaid, Total	-	-	-	-	-400M
Long-Term Debt Repaid, Total	-23.36B	-15.15B	-17.88B	-51.02B	-127B
Total Debt Repaid	-23.36B	-15.15B	-17.88B	-51.02B	-127B
Issuance of Common Stock	-	-	-	-	3.28B
Repurchase of Common Stock	-9.46B	-478M	-1.34B	-5.65B	-
Common Dividends Paid	-16.45B	-5.75B	-	-10.32B	-17.26B
Common & Preferred Stock Dividends Paid	-16.45B	-5.75B	-	-10.32B	-17.26B
Other Financing Activities, Total	2.65B	-159M	-138M	-34.65B	-9.62B
Cash from Financing	-7.39B	-19.39B	10.95B	1.84B	-40.52B
Foreign Exchange Rate Adjustments	2.56B	-2.16B	11.66B	2.82B	-4.9B
Net Change in Cash	4.18B	15.1B	39.95B	-10.08B	-42.6B
Supplemental Items
Cash Interest Paid	4.63B	2.08B	6.33B	13.7B	18.5B
Cash Income Tax Paid (Refund)	1.8B	23.76B	22.49B	7.83B	9.84B
Levered Free Cash Flow	8.21B	-	14.63B	-13.85B	28.62B
Unlevered Free Cash Flow	10.26B	-	17.09B	-10.56B	30.84B
Change In Net Working Capital	-1.6B	-	-14.72B	6.88B	-15.95B
Net Debt Issued / Repaid	15.87B	-13B	12.42B	52.46B	-16.92B

Fiscal Period: December	2020	2022	2023	2024	2025
Profitability
Return on Assets	6.9	-	9.92	7.2	8.64
Return on Total Capital	8.11	-	11.5	8.27	9.96
Return On Equity %	5.09	-	16.85	13.87	18.63
Return on Common Equity	6.38	-	19.22	15.01	19
Margin Analysis
Gross Profit Margin %	45.09	65.06	50.52	51.19	49.89
SG&A Margin	24.88	13.23	15.59	18.81	15.75
EBITDA Margin %	29.01	53	38.3	30.64	38.58
EBITA Margin %	19.37	48.32	31.34	24.04	24.96
EBIT Margin %	19.36	48.32	31.34	24.04	24.96
Income From Continuing Operations Margin %	3.2	35.39	19.99	15.4	16.74
Net Income Margin %	2.76	35.16	19.9	15.36	16.68
Net Avail. For Common Margin %	2.76	35.16	19.9	15.36	16.68
Normalized Net Income Margin	2.05	27.91	17.97	12.58	14.09
Levered Free Cash Flow Margin	6.85	-	8.15	-6.99	12.04
Unlevered Free Cash Flow Margin	8.56	-	9.52	-5.33	12.98
Asset Turnover
Asset Turnover	0.57	-	0.51	0.48	0.55
Fixed Assets Turnover	0.8	-	0.88	0.81	0.83
Receivables Turnover (Average Receivables)	25.74	-	5.9	7.5	8.98
Inventory Turnover (Average Inventory)	3.69	-	2.81	2.78	3.45
Short Term Liquidity
Current Ratio	0.8	2.97	1.59	1.13	0.88
Quick Ratio	0.43	2.1	1.14	0.8	0.53
Operating Cash Flow to Current Liabilities	0.44	1.62	0.66	0.18	0.51
Days Sales Outstanding (Average Receivables)	14.22	-	61.82	48.8	40.63
Days Outstanding Inventory (Average Inventory)	99.2	-	129.93	131.5	105.95
Average Days Payable Outstanding	38.98	-	38.68	44.95	36.56
Cash Conversion Cycle (Average Days)	74.44	-	153.07	135.35	110.01
Long Term Solvency
Total Debt/Equity	171.24	40.8	45.88	83.13	65.71
Total Debt / Total Capital	63.13	28.98	31.45	45.39	39.65
LT Debt/Equity	116.93	35.93	20.61	38.79	35.71
Long-Term Debt / Total Capital	43.11	25.52	14.13	21.18	21.55
Total Liabilities / Total Assets	68.74	39.22	40.49	52.26	48.07
EBIT / Interest Expense	7.06	41.8	14.26	9.05	16.69
EBITDA / Interest Expense	10.75	45.85	17.43	11.54	25.79
(EBITDA - Capex) / Interest Expense	5.29	35.94	5.95	2.7	10.45
Total Debt / EBITDA	3.34	0.58	1.54	2.87	1.56
Net Debt / EBITDA	2.9	0.3	0.4	1.74	1.28
Total Debt / (EBITDA - Capex)	6.78	0.74	4.51	12.28	3.85
Net Debt / (EBITDA - Capex)	5.89	0.38	1.17	7.46	3.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.38	-	-30.22	10.43	19.92
Gross Profit, 1 Yr. Growth %	-1.82	-	-45.82	11.89	16.88
EBITDA, 1 Yr. Growth %	-1.5	-	-49.58	-11.67	50.97
EBITA, 1 Yr. Growth %	-4.91	-	-54.74	-15.29	24.48
EBIT, 1 Yr. Growth %	-4.92	-	-54.75	-15.29	24.51
Earnings From Cont. Operations, 1 Yr. Growth %	-84.52	-	-60.6	-14.91	30.33
Net Income, 1 Yr. Growth %	-86.33	-	-60.5	-14.79	30.24
Normalized Net Income, 1 Yr. Growth %	-87.02	-	-55.07	-22.73	34.33
Diluted EPS Before Extra, 1 Yr. Growth %	-85.82	-	-60.43	-14.12	30.45
Accounts Receivable, 1 Yr. Growth %	99.26	-	-42.89	39.13	-27.93
Inventory, 1 Yr. Growth %	17.85	-	13.86	6.52	-7.18
Net Property, Plant and Equip., 1 Yr. Growth %	7.74	-	21.24	20.37	13.7
Total Assets, 1 Yr. Growth %	9.85	-	20.84	13.21	-4.6
Tangible Book Value, 1 Yr. Growth %	-30	-	20.97	-0.74	6.55
Common Equity, 1 Yr. Growth %	-30	-	20.97	-0.74	6.55
Cash From Operations, 1 Yr. Growth %	-7.38	-	-4.69	-61.38	135.64
Capital Expenditures, 1 Yr. Growth %	-5.7	-	53.68	2.79	17.19
Levered Free Cash Flow, 1 Yr. Growth %	-9.66	-	-	-194.7	-306.62
Unlevered Free Cash Flow, 1 Yr. Growth %	4.88	-	-	-161.81	-391.95
Dividend Per Share, 1 Yr. Growth %	-94.37	-	-	25.06	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.32	46.48	-	-12.22	15.07
Gross Profit, 2 Yr. CAGR %	0.4	75.95	-	-22.14	14.36
EBITDA, 2 Yr. CAGR %	-3.13	98.01	-	-33.26	15.48
EBITA, 2 Yr. CAGR %	-9	131.37	-	-38.08	2.69
EBIT, 2 Yr. CAGR %	-9.01	131.42	-	-38.09	2.7
Earnings From Cont. Operations, 2 Yr. CAGR %	-46.33	387.15	-	-42.1	5.31
Net Income, 2 Yr. CAGR %	-49.08	422.7	-	-41.98	5.35
Normalized Net Income, 2 Yr. CAGR %	-54.96	440.69	-	-41.07	1.88
Diluted EPS Before Extra, 2 Yr. CAGR %	-47.96	429.1	-	-41.71	5.85
Accounts Receivable, 2 Yr. CAGR %	32.88	149.79	-	-10.86	0.14
Inventory, 2 Yr. CAGR %	7.43	23.76	-	10.13	-0.57
Net Property, Plant and Equip., 2 Yr. CAGR %	9.34	8.67	-	20.8	16.99
Total Assets, 2 Yr. CAGR %	8.55	20.74	-	16.96	3.92
Tangible Book Value, 2 Yr. CAGR %	-13.89	98.49	-	9.58	2.84
Common Equity, 2 Yr. CAGR %	-13.89	98.49	-	9.58	2.84
Cash From Operations, 2 Yr. CAGR %	-3.98	58.08	-	-39.33	-4.6
Capital Expenditures, 2 Yr. CAGR %	11.09	28.12	-	25.69	9.76
Levered Free Cash Flow, 2 Yr. CAGR %	2.67	-	-	-	39.88
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.04	-	-	-	34.33
Dividend Per Share, 2 Yr. CAGR %	-68.64	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.31	30.84	14.4	-	-2.6
Gross Profit, 3 Yr. CAGR %	8.4	44.85	18.82	-	-10.85
EBITDA, 3 Yr. CAGR %	5.25	56.9	25.51	-	-12.39
EBITA, 3 Yr. CAGR %	2.01	72.02	34.31	-	-21.85
EBIT, 3 Yr. CAGR %	2.01	72.04	34.32	-	-21.85
Earnings From Cont. Operations, 3 Yr. CAGR %	-35.45	54.29	110.67	-	-24.12
Net Income, 3 Yr. CAGR %	-37.31	55.14	120.99	-	-24.04
Normalized Net Income, 3 Yr. CAGR %	-38.1	55.98	135.95	-	-22.45
Diluted EPS Before Extra, 3 Yr. CAGR %	-36.09	58.33	122.92	-	-23.75
Accounts Receivable, 3 Yr. CAGR %	39.85	131.66	52.74	-	-16.96
Inventory, 3 Yr. CAGR %	8.89	21.75	20.37	-	4.03
Net Property, Plant and Equip., 3 Yr. CAGR %	8.74	8.36	12.71	-	18.39
Total Assets, 3 Yr. CAGR %	5.6	16.99	20.77	-	9.28
Tangible Book Value, 3 Yr. CAGR %	-15.31	40.24	68.28	-	8.56
Common Equity, 3 Yr. CAGR %	-15.31	40.24	68.28	-	8.56
Cash From Operations, 3 Yr. CAGR %	16.34	32.28	33.55	-	-4.63
Capital Expenditures, 3 Yr. CAGR %	16.67	15.68	36.13	-	22.79
Levered Free Cash Flow, 3 Yr. CAGR %	-14.92	-	21.23	-	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.58	-	18.53	-	-
Dividend Per Share, 3 Yr. CAGR %	-61.65	-	142.35	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.43	22.21	10.68	11.53	14.67
Gross Profit, 5 Yr. CAGR %	-0.07	31.57	11.08	13	17.01
EBITDA, 5 Yr. CAGR %	-3.23	35.53	13.16	11.46	21.4
EBITA, 5 Yr. CAGR %	-8.78	41.55	14.94	14.31	20.63
EBIT, 5 Yr. CAGR %	-8.79	41.56	14.94	14.31	20.64
Earnings From Cont. Operations, 5 Yr. CAGR %	-26.49	44.88	21.91	4.25	59.64
Net Income, 5 Yr. CAGR %	-25.82	46.43	22.85	4.68	64.31
Normalized Net Income, 5 Yr. CAGR %	-28.32	47.29	21.66	5.67	68.63
Diluted EPS Before Extra, 5 Yr. CAGR %	-26.04	48.85	24.57	6.17	65.49
Accounts Receivable, 5 Yr. CAGR %	22.16	76.37	44.46	58.11	29.01
Inventory, 5 Yr. CAGR %	1.63	14.61	15.01	16.96	11.51
Net Property, Plant and Equip., 5 Yr. CAGR %	5.87	8.71	11.35	13.17	14.4
Total Assets, 5 Yr. CAGR %	-0.6	11.41	15.73	16.98	13.73
Tangible Book Value, 5 Yr. CAGR %	-12.6	19.07	28.72	27.06	38.2
Common Equity, 5 Yr. CAGR %	-12.86	19.07	28.72	27.06	38.2
Cash From Operations, 5 Yr. CAGR %	-6.44	31.52	17.04	-3.15	16.73
Capital Expenditures, 5 Yr. CAGR %	3.5	21.13	25.5	19.59	24.9
Levered Free Cash Flow, 5 Yr. CAGR %	-5.92	-	13.43	8.79	28.37
Unlevered Free Cash Flow, 5 Yr. CAGR %	-5.59	-	14.22	1.54	24.61
Dividend Per Share, 5 Yr. CAGR %	-30.12	-	6.96	0.04	-